Pharmacology of Antitubercular and Antifungal Drugs

Join our CE course for Nurses and Nurse Practitioners (NPs) on the Pharmacology of Antitubercular and Antifungal Drugs to gain comprehensive insights into the effective management of tuberculosis and fungal infections. This course explores the fundamental pharmacological principles, mechanisms of action, and clinical applications of key antitubercular and antifungal medications.

Participants will learn to identify adverse effects and drug interactions, implement patient-centered care strategies, and understand mechanisms of resistance. The course emphasizes the importance of clinical monitoring, particularly regarding hepatic and renal functions, and equips learners to make informed decisions in complex care scenarios.

As resistance to both TB and fungal treatments becomes an increasing challenge in healthcare, this program is designed to strengthen the clinical capabilities of nurses and NPs in providing safe, effective, and evidence-based care. With real-world examples and guidance aligned to current clinical practice, this course supports nurses in enhancing therapeutic outcomes, ensuring compliance with regulatory requirements, and improving the quality of patient care.

Educational Objectives

1. Explain the pharmacological properties, mechanisms of action, and clinical uses of key antitubercular and antifungal drugs.
2. Identify common adverse effects and significant drug-drug interactions associated with these medications.
3. Integrate nursing-specific considerations to enhance the safe and effective administration of antitubercular and antifungal therapies.
4. Understand resistance patterns in tuberculosis and fungal infections and apply best practices for preventing resistance.
5. Implement appropriate clinical monitoring for patients, including liver and renal function assessments, throughout treatment.

Who Should Do This Course

This course is designed for Registered Nurses (RNs) and Nurse Practitioners (NPs) who are involved in prescribing, administering, or monitoring pharmacological treatments for tuberculosis and fungal infections. It is especially relevant for clinicians practicing in states where license renewal requirements include advanced pharmacology, pharmacotherapeutics, or general pharmacology-related topics.

This course fulfills state-mandated license renewal requirements for:

• Advanced Pharmacology – Nursing: Ohio, Alaska
• Pharmacotherapeutics – Nursing: Hawaii, Louisiana, Oklahoma, West Virginia, Connecticut, Arkansas, Illinois, Nebraska, South Carolina, Texas, Washington, Wisconsin
• Pharmacology – Nursing: Alabama, Indiana

Did You Know?

• Globally, tuberculosis was the 13th leading cause of death and the second leading infectious killer after COVID-19 in 2022 (WHO, 2023).
• Drug-resistant TB accounts for about 500,000 cases annually and poses a major global health threat.
• Fungal infections cause over 1.5 million deaths globally each year—more than malaria or tuberculosis (GAFFI, 2022).
• Itraconazole and amphotericin B are among the most potent antifungal agents but are associated with significant renal and hepatic toxicity.
• Early recognition and pharmacological intervention are critical in reducing mortality related to invasive fungal infections and TB.